Dow Up 0.21% Nasdaq Down 0.16%

Medivation, Inc. (MDVN)

-NMS
102.63 Up 1.70(1.68%) 11:55AM EDT - Nasdaq Real Time Price
Prev Close:100.93
Open:101.20
Bid:102.35 x 800
Ask:102.38 x 100
1y Target Est:106.00
Beta:0.04
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:101.20 - 103.21
52wk Range:48.15 - 103.21
Volume:672,141
Avg Vol (3m):1,027,800
Market Cap:7.88B
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MDVNUp 1.68%7.88B
ABTUp 0.27%65.88B
DNDNUp 0.70%222.26M
JNJUp 0.71%304.90B

Key Statistics

Forward P/E (1 yr):29.75
P/S (ttm):19.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :2.44
Quarterly EPS Est (Sep-14) :0.82
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback